サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1449448

フィナステリド市場、シェア、規模、動向、産業分析レポート：製品別、用途別、流通チャネル別、地域別、セグメント別予測、2024年～2032年

Finasteride Market Share, Size, Trends, Industry Analysis Report, By Product (1mg, 5mg); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032
出版日: | 発行: Polaris Market Research | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
フィナステリド市場、シェア、規模、動向、産業分析レポート：製品別、用途別、流通チャネル別、地域別、セグメント別予測、2024年～2032年
出版日: 2024年02月24日
発行: Polaris Market Research
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、フィナステリドの世界市場規模は2032年までに1億2,877万米ドルに達する見込みです。このレポートは現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

マーケットプレースにおけるフィナステリドの需要増加は、男性のハゲに対する懸念の高まりに起因していると考えられます。男性の間では30歳でハゲの兆候が現れ、60歳までには完全にハゲてしまうという有病率が、植毛とケアに対する時代のニーズを駆り立てています。フィナステリドは、頭皮の男性ホルモンの成長を抑制することで、脱毛症の治療に効果があるとされ、マーケットプレースでの採用を後押ししています。

さらに、男性の健康に対するフィナステリドの利点を評価する研究者の増加も、市場の成長にプラスの影響を与えています。例えば、PubMed Centralに掲載された2023年の研究では、前立腺肥大症におけるフィナステリドの長期的効果の発見に焦点が当てられ、尿閉塞と前立腺肥大を経験している男性においてフィナステリドを4年間投与することで、尿流量が促進され、急性尿閉や手術の可能性が低くなると結論付けられています。より多くの人々がフィナステリドのヘルスケア上の利点を認識するにつれて、今後数年間で需要が急増すると思われます。

また、製薬会社や学者によるフィナステリド錠剤の経口摂取に関連する副作用に対抗するための調査研究が進展していることも、市場の拡大を後押ししています。例えば、2023年3月には、Boryung Companyが韓国で初めてスプレータイプのフィナステリド配合薄毛治療薬を発表しました。こうした技術革新は、マーケットプレースにおけるフィナステリドの需要を当面刺激しそうです。

さらに、フィナステリドの特性を掘り下げる進行中の研究活動は、マーケットプレースにおける新たな成長機会を高めると予測されています。例えば、Science Direct誌に掲載された2023年の研究では、アンドロゲン性脱毛症の治療における経口フィナステリドの副作用を克服するため、毛包を標的とした局所フィナステリド・ニオソームの開発に焦点が当てられています。このような開発は、副作用の少ない効率的な脱毛治療の開発により、患者からの需要を獲得することが期待されます。

フィナステリド市場レポートハイライト

薄毛に悩む男性人口が多いことから、1mgセグメントは今後数年間で最も高い成長が見込まれます。

前立腺肥大のような疾患の抑制に効果的なことから、前立腺肥大セグメントが2023年に最大の市場シェアを占めました。

小売薬局セグメントは、医薬品の流通におけるアクセス性と利便性の向上により、2023年に主要な市場シェアを占めました。

アジア太平洋地域は、予測期間中に最も速い成長を記録すると予測されます。これは、アジア人口の大部分、特に男性の間で脱毛の発生率が上昇していることに起因します。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のフィナステリド市場に関する洞察

  • フィナステリド市場- 流通チャネルのスナップショット
  • フィナステリド市場力学
    • 促進要因と機会
      • 増加する臨床試験により、フィナステリドの真の可能性が解明されつつある
      • ヘアケア複合薬の開発が進む
    • 抑制要因と課題
      • フィナステリド薬の副作用
  • PESTEL分析
  • フィナステリド市場流通チャネルの動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のフィナステリド市場、製品別

  • 主な調査結果
  • イントロダクション
  • 1mg
  • 5mg

第6章 世界のフィナステリド市場、用途別

  • 主な調査結果
  • イントロダクション
  • 前立腺の治療
  • ヘアトリートメント

第7章 世界のフィナステリド市場、流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 小売薬局
  • オンライン薬局
  • 病院薬局

第8章 世界のフィナステリド市場、地域別

  • 主な調査結果
  • イントロダクション
    • フィナステリド市場評価、地域別、2019-2032
  • フィナステリド市場-北米
    • 北米：フィナステリド市場、製品別、2019-2032年
    • 北米：フィナステリド市場、流通チャネル別、2019-2032
    • 北米：フィナステリド市場、用途別、2019-2032年
    • フィナステリド市場-米国
    • フィナステリド市場- カナダ
  • フィナステリド市場- 欧州
    • 欧州：フィナステリド市場、製品別、2019-2032
    • 欧州：フィナステリド市場、流通チャネル別、2019-2032
    • 欧州：フィナステリド市場、用途別、2019～2032年
    • フィナステリド市場- 英国
    • フィナステリド市場- フランス
    • フィナステリド市場- ドイツ
    • フィナステリド市場- イタリア
    • フィナステリド市場- スペイン
    • フィナステリド市場- オランダ
    • フィナステリド市場- ロシア
  • フィナステリド市場- アジア太平洋
    • アジア太平洋：フィナステリド市場、製品別、2019～2032年
    • アジア太平洋：フィナステリド市場、流通チャネル別、2019-2032
    • アジア太平洋：フィナステリド市場、用途別、2019～2032年
    • フィナステリド市場- 中国
    • フィナステリド市場- インド
    • フィナステリド市場- マレーシア
    • フィナステリド市場- 日本
    • フィナステリド市場- インドネシア
    • フィナステリド市場- 韓国
  • フィナステリド市場-中東およびアフリカ
    • 中東およびアフリカ：フィナステリド市場、製品別、2019-2032
    • 中東およびアフリカ：フィナステリド市場、流通チャネル別、2019-2032
    • 中東およびアフリカ：フィナステリド市場、用途別、2019～2032年
    • フィナステリド市場- サウジアラビア
    • フィナステリド市場- アラブ首長国連邦
    • フィナステリド市場- イスラエル
    • フィナステリド市場- 南アフリカ
  • フィナステリド市場-ラテンアメリカ
    • ラテンアメリカ：フィナステリド市場、製品別、2019-2032年
    • ラテンアメリカ：フィナステリド市場、流通チャネル別、2019-2032
    • ラテンアメリカ：フィナステリド市場、用途別、2019-2032年
    • フィナステリド市場- メキシコ
    • フィナステリド市場- ブラジル
    • フィナステリド市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Accord Pharmaceuticals（UK）
  • Teva Pharmaceutical Industries Ltd.
  • Cipla（India）
  • Merck（Germany）
  • Mylan N.V.（US）
  • RelonChem（UK）
  • Sandoz（Switzerland）
  • Topfond Pharmaceutical Co., Ltd.
  • Dr. Reddy's Laboratories（UK）Ltd.
  • Novartis AG
図表

List of Tables

  • Table 1 Global Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 2 Global Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 3 Global Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 4 Finasteride Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 6 North America: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 7 North America: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 8 U.S.: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 9 U.S.: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 10 U.S.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 11 Canada: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 12 Canada: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 13 Canada: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 14 Europe: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 15 Europe: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 16 Europe: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 17 UK: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 18 UK: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 19 UK: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 France: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 21 France: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 22 France: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 23 Germany: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 24 Germany: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 25 Germany: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 26 Italy: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 27 Italy: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 28 Italy: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 29 Spain: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 30 Spain: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 31 Spain: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 32 Netherlands: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 33 Netherlands: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 34 Netherlands: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 Russia: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 36 Russia: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 37 Russia: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 41 China: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 42 China: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 43 China: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 44 India: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 45 India: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 46 India: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 47 Malaysia: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 48 Malaysia: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 49 Malaysia: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Japan: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 51 Japan: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 52 Japan: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 53 Indonesia: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 54 Indonesia: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 55 Indonesia: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 56 South Korea: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 57 South Korea: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 58 South Korea: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 65 UAE: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 66 UAE: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 67 UAE: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 68 Israel: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 69 Israel: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 70 Israel: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 71 South Africa: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 72 South Africa: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 73 South Africa: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 74 Latin America: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 75 Latin America: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 76 Latin America: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 77 Mexico: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 78 Mexico: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 79 Mexico: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 Brazil: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 81 Brazil: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 82 Brazil: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 83 Argentina: Finasteride Market, by Product, 2019-2032 (USD Million)
  • Table 84 Argentina: Finasteride Market, by Application, 2019-2032 (USD Million)
  • Table 85 Argentina: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Finasteride Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Finasteride Market, by Application, 2022 & 2032 (USD Million)
  • Figure 8. Market by Product
  • Figure 9. Global Finasteride Market, by Product, 2022 & 2032 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Finasteride Market, by Distribution Channel, 2022 & 2032 (USD Million)
  • Figure 12. Finasteride Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Finasteride Market
目次
Product Code: PM4627

The global finasteride market size is expected to reach USD 128.77 million by 2032, according to a new study by Polaris Market Research. The report "Finasteride Market Share, Size, Trends, Industry Analysis Report, By Product (1mg, 5mg); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing demand for finasteride in the marketplace can be attributable to the growing concerns about baldness among males. The prevalence of baldness signs among men at the age of 30 and complete baldness by 60 is driving the need of the hour for hair implantation and care. The potential of finasteride medication in the treatment of pattern hair loss by restricting the growth of male hormones at the scalp in the body is boosting its adoption in the marketplace.

Furthermore, rising researchers focus on evaluating the benefits of finasteride for male health is positively impacting market growth. For instance, a 2023 study published in PubMed Central focused on finding the long-term effects of finasteride in benign prostatic hyperplasia and concluded that the treatment of finasteride for four years among men experiencing urinary obstruction and prostatic enlargement promoted the rate of urinary flow and a lower chance of acute urinary retention and surgery. As more people identify the healthcare benefits of finasteride, there will be an upsurge in its demand in the next few years.

In addition, the evolving research studies to counter the side effects associated with the oral intake of finasteride pills by pharmaceutical companies and academicians are boosting market expansion. For instance, in March 2023, Boryung Company unveiled the initial spray-type finasteride-based hair loss drug in Korea. These innovations are likely to stimulate the demand for finasteride in the marketplace in the foreseeable future.

Moreover, the ongoing research activities delving into the properties of finasteride are projected to enhance new growth opportunities in the marketplace. For instance, a 2023 study published in Science Direct focused on the development of topical finasteride niosomes targeting hair follicles to overcome the oral finasteride side effects for the treatment of androgenic alopecia. These types of developments are expected to gain demand from patients, driven by the development of efficient hair loss treatments with lower side effects.

Finasteride Market Report Highlights

1mg segment is anticipated to witness the highest growth in the coming years due to the presence of a larger number of men's population suffering from hair loss.

Prostate enlargement segment accounted for the largest market share in 2023, owing to its effective performance in controlling the disease such as prostate enlargement.

Retail pharmacies segment held a major market share in 2023, due to its enhanced accessibility and convenience in distribution of medicines.

Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the rising incidence of hair fall among larger section of the Asian populations specifically among men.

The global players include Accord Pharmaceuticals, Actavis, Cipla, Henan Topfond, Merck, Mylan N.V., RelonChem, Sandoz, Teva Pharmaceuticals, and others.

Polaris Market Research has segmented the finasteride market report based on product, application, distribution channel and region:

Finasteride, Product Outlook (Revenue - USD Million, 2019 - 2032)

  • 1mg
  • 5mg

Finasteride, Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Prostate Treatment
  • Prostate Enlargement
  • Prostate Cancer
  • Hormone Therapy (Transgender Women)
  • Hair Treatment
  • Scalp Hair Loss
  • Excessive Hair Growth

Finasteride, Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies

Finasteride, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of LA
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Finasteride Market Insights

  • 4.1. Finasteride Market - Distribution Channel Snapshot
  • 4.2. Finasteride Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising clinical trials are unraveling the true potential of finasteride
      • 4.2.1.2. The growing development of compound hair care medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. The adverse effects of finasteride medication
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Finasteride Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Finasteride Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Finasteride Market, by Product, 2019-2032 (USD Million)
  • 5.3. 1mg
    • 5.3.1. Global Finasteride Market, by 1mg, by Region, 2019-2032 (USD Million)
  • 5.4. 5mg
    • 5.4.1. Global Finasteride Market, by 5mg, by Region, 2019-2032 (USD Million)

6. Global Finasteride Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Finasteride Market, by Application, 2019-2032 (USD Million)
  • 6.3. Prostate Treatment
    • 6.3.1. Global Finasteride Market, by Prostate Treatment, by Region, 2019-2032 (USD Million)
  • 6.4. Hair Treatment
    • 6.4.1. Global Finasteride Market, by Hair Treatment, by Region, 2019-2032 (USD Million)

7. Global Finasteride Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
  • 7.3. Retail Pharmacies
    • 7.3.1. Global Finasteride Market, by Retail Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.4. Online Pharmacies
    • 7.4.1. Global Finasteride Market, by Online Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.5. Hospital Pharmacies
    • 7.5.1. Global Finasteride Market, by Hospital Pharmacies, By Region, 2019-2032 (USD Million)

8. Global Finasteride Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Finasteride Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Finasteride Market - North America
    • 8.3.1. North America: Finasteride Market, by Product, 2019-2032 (USD Million)
    • 8.3.2. North America: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.3. North America: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.3.4. Finasteride Market - U.S.
      • 8.3.4.1. U.S.: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.3.5. Finasteride Market - Canada
      • 8.3.5.1. Canada: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Finasteride Market, by Application, 2019-2032 (USD Million)
  • 8.4. Finasteride Market - Europe
    • 8.4.1. Europe: Finasteride Market, by Product, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.3. Europe: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.4.4. Finasteride Market - UK
      • 8.4.4.1. UK: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.4.5. Finasteride Market - France
      • 8.4.5.1. France: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.5.3. France: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.4.6. Finasteride Market - Germany
      • 8.4.6.1. Germany: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.4.7. Finasteride Market - Italy
      • 8.4.7.1. Italy: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.4.8. Finasteride Market - Spain
      • 8.4.8.1. Spain: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.4.9. Finasteride Market - Netherlands
      • 8.4.9.1. Netherlands: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.4.10. Finasteride Market - Russia
      • 8.4.10.1. Russia: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Finasteride Market, by Application, 2019-2032 (USD Million)
  • 8.5. Finasteride Market - Asia Pacific
    • 8.5.1. Asia Pacific: Finasteride Market, by Product, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.5.4. Finasteride Market - China
      • 8.5.4.1. China: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.4.3. China: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.5.5. Finasteride Market - India
      • 8.5.5.1. India: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.5.3. India: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.5.6. Finasteride Market - Malaysia
      • 8.5.6.1. Malaysia: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.5.7. Finasteride Market - Japan
      • 8.5.7.1. Japan: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.5.8. Finasteride Market - Indonesia
      • 8.5.8.1. Indonesia: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.5.9. Finasteride Market - South Korea
      • 8.5.9.1. South Korea: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Finasteride Market, by Application, 2019-2032 (USD Million)
  • 8.6. Finasteride Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Finasteride Market, by Product, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.6.4. Finasteride Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.6.5. Finasteride Market - UAE
      • 8.6.5.1. UAE: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.6.6. Finasteride Market - Israel
      • 8.6.6.1. Israel: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.6.7. Finasteride Market - South Africa
      • 8.6.7.1. South Africa: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Finasteride Market, by Application, 2019-2032 (USD Million)
  • 8.7. Finasteride Market - Latin America
    • 8.7.1. Latin America: Finasteride Market, by Product, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.7.4. Finasteride Market - Mexico
      • 8.7.4.1. Mexico: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.7.5. Finasteride Market - Brazil
      • 8.7.5.1. Brazil: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Finasteride Market, by Application, 2019-2032 (USD Million)
    • 8.7.6. Finasteride Market - Argentina
      • 8.7.6.1. Argentina: Finasteride Market, by Product, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Finasteride Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Finasteride Market, by Application, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Accord Pharmaceuticals (UK)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Teva Pharmaceutical Industries Ltd.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Cipla (India)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Merck (Germany)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Mylan N.V. (US)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. RelonChem (UK)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Sandoz (Switzerland)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Topfond Pharmaceutical Co., Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Dr. Reddy's Laboratories (UK) Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Novartis AG
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development